Quick Answer
Vaxart, Inc. reported Cash And Cash Equivalents At Carrying Value of $34.76 million for the year ending 2023.
- Vaxart, Inc. showed a decrease of -21.0% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
- This data is from Vaxart, Inc.'s annual report (Form 10-K), filed with the SEC on March 14, 2024.
- XBRL data for this metric is available from 2008 to 2023 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2023), Vaxart, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 67.3%.
- Historical annual values: Fiscal year 2023: $34.76 million | Fiscal year 2022: $44.01 million | Fiscal year 2021: $143.75 million | Fiscal year 2018: $11.51 million | Fiscal year 2017: $1.57 million | Fiscal year 2017: $17.70 million | Fiscal year 2016: $8.41 million | Fiscal year 2016: $49.70 million | Fiscal year 2015: $44.70 million | Fiscal year 2014: $81.70 million | Fiscal year 2013: $66.80 million | Fiscal year 2012: $53.80 million | Fiscal year 2011: $94.31 million | Fiscal year 2011: $74.20 million | Fiscal year 2010: $53.56 million | Fiscal year 2010: $89.80 million | Fiscal year 2009: $59.51 million | Fiscal year 2008: $106.44 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: